Roidipedia.Compound reference & reporting
06 AUG 2026
CompoundsResearch chemical 25P-NBOMe
Research chemicalResearch chemicalPhenethylaminePsychedelicN-benzyl (NBOMe)5-HT2A agonist

25P-NBOMe

Also known as 2C-P-NBOMe · 25P

25P-NBOMe is the N-(2-methoxybenzyl) derivative of 2C-P, one of the more potent 2C compounds. It is a strong, long-acting 5-HT2A agonist psychedelic active in the microgram range, orally inactive, and carries the NBOMe class hazards of narrow margin, vasoconstriction and seizures.

01 Overview

25P-NBOMe combines the potent 2C-P scaffold with the NBOMe modification, producing a very potent and unusually long-lasting psychedelic. It has been sold as blotter and detected in forensic samples.

Human information is anecdotal, and the very long duration (often reported at 10-16 hours) raises the risk of anxious redosing and prolonged cardiovascular strain. Class toxicity — vasoconstriction, agitation, seizures — applies fully.

02 Mechanism

Potent, high-efficacy agonist at 5-HT2A receptors; the N-2-methoxybenzyl group amplifies the already high 5-HT2A affinity of the 2C-P backbone.

03 Dosing

TierDoseRouteNotes
Threshold100–300 µgSublingualVery potent; estimated.
Common300–900 µgSublingualAnecdotal; very long duration.

04 Effects

EffectMagnitudeEvidence
Prolonged psychedelic experienceIntense, long-lasting visuals and cognitive alteration, among the longest of the NBOMe series.10-16 hAnecdotal
StimulationStrong body load, tension and insomnia.markedAnecdotal

05 Side effects

EffectSeverityFrequencyEvidenceCountermeasures
Severe vasoconstrictionCold, painful extremities and sustained hypertension over the long duration.SevereCommonAnecdotal
Anxiety, agitation and seizuresLong duration can produce escalating anxiety, panic and, at high doses, seizures.SevereUncommonAnecdotal

07 References

NBOMe hallucinogens: pharmacology and clinical toxicologyNeuropharmacology, 2018
EMCDDA NBOMe overviewEMCDDA

08 Discussion0 comments

?
Sign in to add a comment…
Create account
Discussion is moderated. No sourcing, vendor names or price talk — those comments are removed, and repeat posts are banned.
This page is reference information, not medical advice. Doses and protocols are documented as they appear in the clinical literature and in practice — describing them is not a recommendation to use them. Countermeasures listed here are not a substitute for a physician. Legal status varies by jurisdiction and changes.